Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityNo recent work listed

Xin Dai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0472-700X; OpenAlex author ID A5040773949. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper

Papers 4

  1. Exosomal miR-19a decreases insulin production by targeting Neurod1 in pancreatic cancer associated diabetes. Last author DOI 10.1007/s11033-021-06980-z↗
  2. Pancreatic cancer-derived exosomal microRNA-19a induces β-cell dysfunction by targeting ADCY1 and EPAC2. Co-author DOI 10.7150/ijbs.56271↗
  3. Altered profile of serum microRNAs in pancreatic cancer-associated new-onset diabetes mellitus. Co-author DOI 10.1111/1753-0407.12313↗
  4. Pancreatic cancer-secreted miR-155 implicates in the conversion from normal fibroblasts to cancer-associated fibroblasts. Co-author DOI 10.1111/cas.12747↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wenjing Pang · 4 shared papers, 2015–2022 · strength 0.42
  2. Weiyan Yao · 4 shared papers, 2015–2022 · strength 0.42
  3. Lei Li · 2 shared papers, 2021–2022 · strength 0.31
  4. Jiaojiao Su · 2 shared papers, 2015–2022 · strength 0.24
  5. Xiangjun Meng · 1 shared paper, 2021 · strength 0.13
  6. Yaozong Yuan · 2 shared papers, 2015–2016 · strength 0.11
  7. Cheng Wang · 1 shared paper, 2016 · strength 0.06
  8. Lu Xia · 1 shared paper, 2016 · strength 0.06
  9. Hui Feng · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.